Long-term acetyl-L-carnitine treatment in Alzheimer's disease.

  title={Long-term acetyl-L-carnitine treatment in Alzheimer's disease.},
  author={Alberto Spagnoli and Ugo da Lucca and G Menasce and Lia Bandera and Giovanni Cizza and Gianluigi Forloni and Mauro Tettamanti and Lucilla Frattura and Pietro Tiraboschi and Mario Angelo Comelli},
  volume={41 11},
In a double-blind, placebo-controlled, parallel-group, randomized clinical trial, we studied the efficacy of long-term (1-year) oral treatment with acetyl-L-carnitine in 130 patients with a clinical diagnosis of Alzheimer's disease. We employed 14 outcome measures to assess functional and cognitive impairment. After 1 year, both the treated and placebo groups worsened, but the treated group showed a slower rate of deterioration in 13 of the 14 outcome measures, reaching statistical significance… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 69 extracted citations

Pharmacological Treatment of Dementia: Summary

View 6 Excerpts
Highly Influenced

L-carnitine for cognitive enhancement in people without cognitive impairment.

Ning Chen, Mi Yang, +3 authors Li He
The Cochrane database of systematic reviews • 2017

Similar Papers

Loading similar papers…